FDA Nanotech Guidance Draws Industry Comment On Particle Size Criteria

FDA's draft guidance to industry suggesting that ingredients up to 1 micrometer in size still qualify as nanomaterials if they exhibit “altered properties” should be revised to avoid confusion in the marketplace and promote international harmonization, according to the Personal Care Products Council.

More from Archive

More from HBW Insight